SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-043866
Filing Date
2024-04-12
Accepted
2024-04-12 08:00:15
Documents
5
Period of Report
2024-05-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A proxy_2023_live.htm DEF 14A 535862
2 GRAPHIC img53694363_0.jpg GRAPHIC 100951
3 GRAPHIC img53694363_1.jpg GRAPHIC 2747
4 GRAPHIC img53694363_2.jpg GRAPHIC 997207
5 GRAPHIC img53694363_3.jpg GRAPHIC 771881
  Complete submission text file 0000950170-24-043866.txt   3116216
Mailing Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380
Business Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 353 1 905 8020
Mural Oncology plc (Filer) CIK: 0001971543 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41837 | Film No.: 24840017
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)